Selection and characterisation of guanidine-resistant mutants of human enterovirus 71

Virus Research

Volumn 169, Issue 1, 2012, Pages 72-79

  Sadeghipour, Sara ^a   Bek, Emily J ^a   McMinn, Peter C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Guanidine resistance; Human enterovirus 71; Protein 2C

Indexed keywords

COMPLEMENTARY DNA; GUANIDINE; NON STRUCTURAL PROTEIN 2C; NONSTRUCTURAL PROTEIN 2; UNCLASSIFIED DRUG; VIRUS RNA;

AMINO ACID SUBSTITUTION; ARTICLE; ENTEROVIRUS 71; GENE MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS CHARACTERIZATION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; CARRIER PROTEINS; CERCOPITHECUS AETHIOPS; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, VIRAL; ENTEROVIRUS A, HUMAN; GUANIDINE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; RNA, VIRAL; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA; VERO CELLS; VIRAL NONSTRUCTURAL PROTEINS;

HUMAN ENTEROVIRUS 71;

EID: 84867216899     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.07.005     Document Type: Article

References (44)

1. Adams P., Kandiah E., Effantin G., Steven A.C., Ehrenfeld E. Poliovirus 2C protein forms homo-oligomeric structures required for ATPase activity. Journal of Biological Chemistry 2009, 284(33):22012-22021.
2. Anderson-Sillman K., Bartal S., Tershak D.R. Guanidine-resistant poliovirus mutants produce modified 37-kilodalton proteins. Journal of Virology 1984, 50(3):922-928.
3. Baltera R.F., Tershak D.R. Guanidine-resistant mutants of poliovirus have distinct mutations in peptide 2C. Journal of Virology 1989, 63(10):4441-4444.
4. Barton D., Flanegan J. Synchronous replication of poliovirus RNA: initiation of negative- strand RNA synthesis requires the guanidine-inhibited activity of protein 2C. Journal of Virology 1997, 71(11):8482-8489.
5. Belsham G.J., Normann P. Dynamics of picornavirus RNA replication within infected cells. Journal of General Virology 2008, 89(2):485-493.
6. Bible J.M., Iturriza-Gomara M., Megson B., Brown D., Pantelidis P., Earl P., Bendig J., Tong C.Y.W. Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. Journal of Clinical Microbiology 2008, 46(10):3192-3200.
7. Bienz K., Egger D., Troxler M., Pasamontes L. Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region. Journal of Virology 1990, 64(3):1156-1163.
8. Chang L.-Y., Chang I.S., Chen W.-J., Huang Y.-C., Chen G.-W., Shih S.-R., Juang J.-L., Shih H.-M., Hsiung C.A., Lin T.-Y., Huang L.-M. HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics 2008, 122(6):1271-1276.
9. Chua B.H., Phuektes P., Sanders S.A., Nicholls P.K., McMinn P.C. The molecular basis of mouse adaptation by human enterovirus 71. Journal of General Virology 2008, 89(7):1622-1632.
10. Chua K., Kasri A. Hand foot and mouth disease due to enterovirus 71 in Malaysia. Virologica Sinica 2011, 26(4):221-228.
11. Crotty S., Maag D., Arnold J.J., Zhong W., Lau J.Y.N., Hong Z., Andino R., Cameron C.E. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nature Medicine 2000, 6(12):1375-1379.
12. Finn R.D., Mistry J., Tate J., Coggill P., Heger A., Pollington J.E., Gavin O.L., Gunasekaran P., Ceric G., Forslund K., Holm L., Sonnhammer E.L.L., Eddy S.R., Bateman A. The Pfam protein families database. Nucleic Acids Research 2010, 38(Suppl 1):D211-D222.
13. Gaudernak E., Seipelt J., Triendl A., Grassauer A., Kuechler E. Antiviral effects of pyrrolidine dithiocarbamate on human rhinoviruses. Journal of Virology 2002, 76(12):6004-6015.
14. Goujon M., McWilliam H., Li W., Valentin F., Squizzato S., Paern J., Lopez R. A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Research 2010, 38(Suppl 2):W695-W699.
15. Klein M., Hadaschik D., Zimmermann H., Eggers H.J., Nelsen-Salz B. The picornavirus replication inhibitors HBB and guanidine in the echovirus-9 system: the significance of viral protein 2C. Journal of General Virology 2000, 81(4):895-901.
16. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23(21):2947-2948.
17. Mathews D.H., Sabina J., Zuker M., Turner D.H. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. Journal of Molecular Biology 1999, 288(5):911-940.
18. McMinn P., Stratov I., Nagarajan L., Davis S. Neurological manifestations of enterovirus 71 infection in children during an Outbreak of Hand, Foot, and Mouth Disease in Western Australia. Clinical Infectious Diseases 2001, 32(2):236-242.
19. Murray K.E., Barton D.J. Poliovirus CRE-dependent VPg uridylylation is required for positive-strand RNA synthesis but not for negative-strand RNA synthesis. Journal of Virology 2003, 77(8):4739-4750.
20. Pariente N., Sierra S., Lowenstein P.R., Domingo E. Efficient virus extinction by combinations of a mutagen and antiviral inhibitors. Journal of Virology 2001, 75(20):9723-9730.
21. Pfeiffer J.K., Kirkegaard K. A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proceedings of the National Academy of Sciences 2003, 100(12):7289-7294.
22. Pfister T., Wimmer E. Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication. Journal of Biological Chemistry 1999, 274(11):6992-7001.
23. Pincus S.E., Diamond D.C., Emini E.A., Wimmer E. Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. Journal of Virology 1986, 57(2):638-646.
24. Pincus S.E., Rohl H., Wimmer E. Guanidine-dependent mutants of poliovirus: identification of three classes with different growth requirements. Virology 1987, 157(1):83-88.
25. Pincus S.E., Wimmer E. Production of guanidine-resistant and -dependent poliovirus mutants from cloned cDNA: mutations in polypeptide 2C are directly responsible for altered guanidine sensitivity. Journal of Virology 1986, 60(2):793-796.
26. Pringle C.R. Inhibition of multiplication of foot-and-mouth disease virus by guanidine hydrochloride. Nature 1964, 204(4962):1012-1013.
27. Quevillon E., Silventoinen V., Pillai S., Harte N., Mulder N., Apweiler R., Lopez R. InterProScan: protein domains identifier. Nucleic Acids Research 2005, 33(Suppl 2):W116-W120.
28. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology 1938, 27(3):493-497.
29. Rodríguez P.L., Carrasco L. Poliovirus protein 2C has ATPase and GTPase activities. Journal of Biological Chemistry 1993, 268(11):8105-8110.
30. Saunders K., King A.M., McCahon D., Newman J.W., Slade W.R., Forss S. Recombination and oligonucleotide analysis of guanidine-resistant foot-and-mouth disease virus mutants. Journal of Virology 1985, 56(3):921-929.
31. Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. The Lancet Infectious Diseases 2010, 10(11):778-790.
32. m of the initiating nucleoside triphosphate for viral RNA replication. Journal of Virology 2008, 82(19):9400-9408.
33. Steil B.P., Barton D.J. Cis-active RNA elements (CREs) and picornavirus RNA replication. Virus Research 2009, 139(2):240-252.
34. Sweeney T.R., Cisnetto V., Bose D., Bailey M., Wilson J.R., Zhang X., Belsham G.J., Curry S. Foot-and-mouth disease virus 2C is a hexameric AAA+ protein with a coordinated ATP hydrolysis mechanism. Journal of Biological Chemistry 2010, 285(32):24347-24359.
35. Tang W.-F., Yang S.-Y., Wu B.-W., Jheng J.-R., Chen Y.-L., Shih C.-H., Lin K.-H., Lai H.-C., Tang P., Horng J.-T. Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication. Journal of Biological Chemistry 2007, 282(8):5888-5898.
36. Tee K.K., Lam T.T.-Y., Chan Y.F., Bible J.M., Kamarulzaman A., Tong C.Y.W., Takebe Y., Pybus O.G. Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. Journal of Virology 2010, 84(7):3339-3350.
37. Tershak D.R. Inhibition of poliovirus polymerase by guanidine in vitro. Journal of Virology 1982, 41(1):313-318.
38. Tolskaya E.A., Romanova L.I., Kolesnikova M.S., Gmyl A.P., Gorbalenya A.E., Agol V.I. Genetic studies on the poliovirus 2C protein, an NTPase A plausible mechanism of guanidine effect on the 2C function and evidence for the importance of 2C oligomerization. Journal of Molecular Biology 1994, 236(5):1310-1323.
39. Vance L., Moscufo N., Chow M., Heinz B. Poliovirus 2C region functions during encapsidation of viral RNA. Journal of Virology 1997, 71(11):8759-8765.
40. Wong S.S.Y., Yip C.C.Y., Lau S.K.P., Yuen K.Y. Human enterovirus 71 and hand, foot and mouth disease. Epidemiology and Infection 2010, 138(08):1071-1089.
41. Wu Y., Lou Z., Miao Y., Yu Y., Dong H., Peng W., Bartlam M., Li X., Rao Z. Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China. Protein & Cell 2010, 1(5):491-500.
42. Yamashita T., Ito M., Tsuzuki H., Sakae K., Minagawa H. Molecular identification of enteroviruses including two new types (EV-98 and EV-107) isolated from Japanese travellers from Asian countries. Journal of General Virology 2010, 91(4):1063-1066.
43. Zheng Z., Li H., Zhang Z., Meng J., Mao D., Bai B., Lu B., Mao P., Hu Q., Wang H. Enterovirus 71 2C protein inhibits TNF-α-mediated activation of NF-κB by suppressing IκB kinase β phosphorylation. The Journal of Immunology 2011, 187(5):2202-2212.
44. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Research 2003, 31(13):3406-3415.